310 related articles for article (PubMed ID: 30421536)
1. Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.
Héritier S; Barkaoui MA; Miron J; Thomas C; Moshous D; Lambilliotte A; Mazingue F; Kebaili K; Jeziorski E; Plat G; Aladjidi N; Pacquement H; Galambrun C; Brugières L; Leverger G; Mansuy L; Paillard C; Deville A; Pagnier A; Lutun A; Gillibert-Yvert M; Stephan JL; Cohen-Aubart F; Haroche J; Pellier I; Millot F; Gandemer V; Martin-Duverneuil N; Taly V; Hélias-Rodzewicz Z; Emile JF; Hoang-Xuan K; Idbaih A; Donadieu J
Br J Haematol; 2018 Nov; 183(4):608-617. PubMed ID: 30421536
[TBL] [Abstract][Full Text] [Related]
2. BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.
Héritier S; Emile JF; Barkaoui MA; Thomas C; Fraitag S; Boudjemaa S; Renaud F; Moreau A; Peuchmaur M; Chassagne-Clément C; Dijoud F; Rigau V; Moshous D; Lambilliotte A; Mazingue F; Kebaili K; Miron J; Jeziorski E; Plat G; Aladjidi N; Ferster A; Pacquement H; Galambrun C; Brugières L; Leverger G; Mansuy L; Paillard C; Deville A; Armari-Alla C; Lutun A; Gillibert-Yvert M; Stephan JL; Cohen-Aubart F; Haroche J; Pellier I; Millot F; Lescoeur B; Gandemer V; Bodemer C; Lacave R; Hélias-Rodzewicz Z; Taly V; Geissmann F; Donadieu J
J Clin Oncol; 2016 Sep; 34(25):3023-30. PubMed ID: 27382093
[TBL] [Abstract][Full Text] [Related]
3. CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions.
McClain KL; Picarsic J; Chakraborty R; Zinn D; Lin H; Abhyankar H; Scull B; Shih A; Lim KPH; Eckstein O; Lubega J; Peters TL; Olea W; Burke T; Ahmed N; Hicks MJ; Tran B; Jones J; Dauser R; Jeng M; Baiocchi R; Schiff D; Goldman S; Heym KM; Wilson H; Carcamo B; Kumar A; Rodriguez-Galindo C; Whipple NS; Campbell P; Murdoch G; Kofler J; Heales S; Malone M; Woltjer R; Quinn JF; Orchard P; Kruer MC; Jaffe R; Manz MG; Lira SA; Parsons DW; Merad M; Man TK; Allen CE
Cancer; 2018 Jun; 124(12):2607-2620. PubMed ID: 29624648
[TBL] [Abstract][Full Text] [Related]
4. Langerhans cell histiocytosis of skull: a retrospective study of 18 cases.
Zhang XH; Zhang J; Chen ZH; Sai K; Chen YS; Wang J; Ke C; Guo CC; Chen ZP; Mou YG
Ann Palliat Med; 2017 Apr; 6(2):159-164. PubMed ID: 28061539
[TBL] [Abstract][Full Text] [Related]
5. Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis. Report from the Japan LCH Study Group.
Imashuku S; Shioda Y; Kobayashi R; Hosoi G; Fujino H; Seto S; Wakita H; Oka A; Okazaki N; Fujita N; Minato T; Koike K; Tsunematsu Y; Morimoto A;
Haematologica; 2008 Apr; 93(4):615-8. PubMed ID: 18287136
[TBL] [Abstract][Full Text] [Related]
6. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004.
Guyot-Goubin A; Donadieu J; Barkaoui M; Bellec S; Thomas C; Clavel J
Pediatr Blood Cancer; 2008 Jul; 51(1):71-5. PubMed ID: 18260117
[TBL] [Abstract][Full Text] [Related]
7. Late outcomes in children with Langerhans cell histiocytosis.
Chow TW; Leung WK; Cheng FWT; Kumta SM; Chu WCW; Lee V; Shing MMK; Li CK
Arch Dis Child; 2017 Sep; 102(9):830-835. PubMed ID: 28442470
[TBL] [Abstract][Full Text] [Related]
8. Pediatric Langerhans cell histiocytosis: the impact of mutational profile on clinical progression and late sequelae.
Nann D; Schneckenburger P; Steinhilber J; Metzler G; Beschorner R; Schwarze CP; Lang P; Handgretinger R; Fend F; Ebinger M; Bonzheim I
Ann Hematol; 2019 Jul; 98(7):1617-1626. PubMed ID: 30923995
[TBL] [Abstract][Full Text] [Related]
9. Pattern and course of neurodegeneration in Langerhans cell histiocytosis.
Wnorowski M; Prosch H; Prayer D; Janssen G; Gadner H; Grois N
J Pediatr; 2008 Jul; 153(1):127-32. PubMed ID: 18571550
[TBL] [Abstract][Full Text] [Related]
10.
Ozer E; Sevinc A; Ince D; Yuzuguldu R; Olgun N
Pediatr Dev Pathol; 2019 Oct; 22(5):449-455. PubMed ID: 31072207
[TBL] [Abstract][Full Text] [Related]
11. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
[TBL] [Abstract][Full Text] [Related]
12. Ethnicity, race, and socioeconomic status influence incidence of Langerhans cell histiocytosis.
Ribeiro KB; Degar B; Antoneli CB; Rollins B; Rodriguez-Galindo C
Pediatr Blood Cancer; 2015 Jun; 62(6):982-7. PubMed ID: 25586293
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Langerhans cell histiocytosis in children: a population-based study.
Stålemark H; Laurencikas E; Karis J; Gavhed D; Fadeel B; Henter JI
Pediatr Blood Cancer; 2008 Jul; 51(1):76-81. PubMed ID: 18266220
[TBL] [Abstract][Full Text] [Related]
14. Differentiating skin-limited and multisystem Langerhans cell histiocytosis.
Simko SJ; Garmezy B; Abhyankar H; Lupo PJ; Chakraborty R; Lim KP; Shih A; Hicks MJ; Wright TS; Levy ML; McClain KL; Allen CE
J Pediatr; 2014 Nov; 165(5):990-6. PubMed ID: 25441388
[TBL] [Abstract][Full Text] [Related]
15. Central diabetes insipidus in pediatric patients with Langerhans cell histiocytosis: Results from the JLSG-96/02 studies.
Sakamoto K; Morimoto A; Shioda Y; Imamura T; Imashuku S;
Pediatr Blood Cancer; 2019 Jan; 66(1):e27454. PubMed ID: 30207064
[TBL] [Abstract][Full Text] [Related]
16. Circulating cell-free BRAF
Héritier S; Hélias-Rodzewicz Z; Lapillonne H; Terrones N; Garrigou S; Normand C; Barkaoui MA; Miron J; Plat G; Aladjidi N; Pagnier A; Deville A; Gillibert-Yvert M; Moshous D; Lefèvre-Utile A; Lutun A; Paillard C; Thomas C; Jeziorski E; Nizard P; Taly V; Emile JF; Donadieu J
Br J Haematol; 2017 Aug; 178(3):457-467. PubMed ID: 28444728
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous adult xanthogranuloma with a small portion of BRAF
Ishikawa M; Endo Y; Uehara A; Suto M; Yasuda M; Motegi SI; Ishikawa O
J Dermatol; 2019 Feb; 46(2):161-165. PubMed ID: 30536719
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome, clinical course and treatment approaches of paediatric langerhans cell histiocytosis: A greek reference centre report.
Tzotzola V; Petrikkos L; Papadakis V; Mitropoulou G; Kelaidi C; Dimitriadis E; Polychronopoulou S
Acta Paediatr; 2021 Jun; 110(6):1944-1951. PubMed ID: 33382132
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous Langerhans cell histiocytosis: study of Asian children shows good overall prognosis.
Ng SS; Koh MJ; Tay YK
Acta Paediatr; 2013 Nov; 102(11):e514-8. PubMed ID: 23909818
[TBL] [Abstract][Full Text] [Related]
20. Langerhans cell histiocytosis in children with congenital anomalies: a population-based record linkage study.
Salotti JA; Tennant PW; Windebank K; Rankin J
Birth Defects Res A Clin Mol Teratol; 2015 Feb; 103(2):157-60. PubMed ID: 25711386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
